scholarly journals VORICONAZOLE-INDUCED HEPATOTOXICITY USED FOR SCEDOSPORIUM AIRWAY COLONIZATION SUPPRESSION THERAPY IN A PATIENT WITH A HISTORY OF A DOUBLE LUNG TRANSPLANT

CHEST Journal ◽  
2021 ◽  
Vol 160 (4) ◽  
pp. A2475
Author(s):  
Kareem Ebeid ◽  
Maie Abdullah ◽  
Zachary Jones
2018 ◽  
Vol 2018 ◽  
pp. 1-5 ◽  
Author(s):  
Jarmanjeet Singh ◽  
Hanine Inaty ◽  
Sanjay Mukhopadhyay ◽  
Atul C. Mehta

Objective. Acute pulmonary silicone embolism (APSE) related to subcutaneous silicone injections is a well-known entity. Recently, a few cases of pathologically confirmed chronic pulmonary silicone embolism (CPSE) from breast implants have been reported. The prevalence of CPSE in women with breast augmentation is unknown. This study was done to determine the prevalence of CPSE in female lung transplant recipients with a history of breast augmentation and to determine whether breast augmentation plays a role in chronic lung diseases requiring lung transplantation. Methods. A retrospective chart review was performed to identify female lung transplant recipients with a history of breast augmentation prior to or at the time of lung transplantation. Ten patients meeting these criteria were identified. The pathologic features of the explanted lungs of these patients were reexamined for CPSE by a board-certified pathologist with expertise in lung transplantation and pulmonary embolism. Results. Of 1518 lung transplant recipients at Cleveland Clinic, 578 were females. Of 578 females, 10 (1.73%) had history of breast augmentation. A total of 84 H&E-stained slides from the explanted lungs from 10 cases were examined. No pathologic evidence of chronic silicone embolism was seen in any of the 10 cases. Conclusions. CPSE is not associated with pulmonary disease leading to lung transplantation. Breast augmentation is not a significant contributor to pulmonary disease requiring lung transplantation. Further studies are required to ascertain the prevalence of CPSE in the general breast augmentation populace and to define the relationship between breast augmentation and pulmonary disease.


2019 ◽  
Vol 107 (4) ◽  
pp. 1017-1023 ◽  
Author(s):  
Sreeja Biswas Roy ◽  
Paul Banks ◽  
Matthew Kunz ◽  
Taylor R. Ipsen ◽  
Takahiro Masuda ◽  
...  

2020 ◽  
Vol 4 (Supplement_1) ◽  
Author(s):  
David Joseph Tansey ◽  
Mensud Hatunic ◽  
John Conneely ◽  
Michelle Murray

Abstract Background: Pheochromocytoma is a rare catecholamine-producing tumor with an estimated incidence of less than 0.1% in the global population. We present the case of a pheochromocytoma in a 25-year-old man with a background history of a double-lung transplant for Cystic Fibrosis, carried out 5 years earlier. Clinical Case: A 25 year old, with a background history of Cystic Fibrosis and a Double Lung transplant in 2012 presented to the emergency department with crampy abdominal pain, nausea and vomiting. He was diagnosed with Distal Intestinal Obstruction syndrome (DIOS) for which he was admitted for rehydration and laxatives. Contrast-enhanced computed tomography (CT) imaging of the abdomen and pelvis which showed a 3.4 cm right adrenal lesion, which was confirmed by a subsequent MRI Adrenals and an Endocrinology review was requested. On review, the patient was noted to be hypertensive with a blood pressure averaging 170/90 despite treatment with 3 different anti-hypertensive medications - namely amlodipine, telmisartan and doxazosin. On review of his medical notes, it was clear that he had been persistently hypertensive over the last 3 years. On further questioning, he noted increasingly frequent sweating episodes over the last number of months but denied any palpitations, headache or back pain. Laboratory analysis showed an elevated plasma normetanephrines (NMN) of 3167 pmol/L (182-867) as well as elevated metanephrines (MN) of 793 pmol/L (61-377) and high 3-MT of 257 pmol/L (<185). His MIBG scan showed only a mild increase in the uptake of tracer to the right adrenal gland compared to the left. The case was discussed at a multidisciplinary meeting and given the suggestive laboratory and radiologic findings, a presumptive diagnosis of pheochromocytoma was made. After controlling blood pressure with an alpha-blocker and beta-blocker for a week, the patient was hydrated and scheduled for an elective right adrenalectomy. The histopathology of the excised adrenal gland was consistent with a 3cm pheochromocytoma with none of the adverse features associated with malignant potential. The patient recovered well post-op, his blood pressure normalised and he was discharged home well for follow-up at the Endocrine and Transplant clinics. Conclusion: We describe a rare case of a right adrenal pheochromocytoma in a young man with multiple co-morbidities, who completely recovered after tumor resection. This case highlights the crucial importance of investigating secondary causes of hypertension, especially in younger patients. This is the first documented case in the literature of a case of pheochromocytoma in a post-transplant patient with Cystic Fibrosis. References: 1. Farrugia FA, Marikos G et al. Pheochromocytoma, diagnosis and treatment: Review of the literature. Endocrine Regulation, Volume 51, Issue 3, 30th August 2017.


2020 ◽  
Vol 39 (9) ◽  
pp. 962-969
Author(s):  
Shuji Okahara ◽  
Bronwyn Levvey ◽  
Mark McDonald ◽  
Rohit D'Costa ◽  
Helen Opdam ◽  
...  

2008 ◽  
Vol 149 (35) ◽  
pp. 1635-1644 ◽  
Author(s):  
Krisztina Czebe ◽  
Eszter Csiszér ◽  
György Lang ◽  
Peter Jaksch ◽  
Walter Klepetko
Keyword(s):  

Az első magyar beteg tüdőtranszplantációja óta 12 év telt el. Magyarországon kicsiny, de lelkes orvoscsoport dolgozik azon, hogy a tüdőátültetés egyre több magyar állampolgár részére könnyen elérhető, evidens terápiás eljárássá váljék. A műtét indikációját végstádiumú, a tüdő vascularis rendszerét vagy parenchymáját érintő megbetegedések képezik, miután a konzervatív terápiás lehetőségek már kimerültek. Jelenleg hazánkban a tüdőtranszplantáció még nem bevezetett műtéti eljárás. Az elmúlt 12 év során (1996 és 2007 decembere között) 64 magyar betegnél végzett tüdőátültetést a Klepetko professzor által vezetett munkacsoport (Vienna Lung Transplant Group) a bécsi sebészeti klinikán. Betegeinknél a következő alapbetegségek miatt került sor transzplantációra: cisztás fibrosis (22), idiopathiás tüdőfibrosis (18), primer pulmonalis hypertonia (8), lymphangioleiomyomatosis (5), emphysema (4) és egyéb betegségek (7 esetben). A 64 betegnél összesen 68 transzplantáció történt. Négy esetben retranszplantációra került sor. A műtéti technika kétoldali teljes tüdő- (33), kétoldali lebenytranszplantáció (18), egyoldali tüdőtranszplantáció (13), szív-tüdő együttes átültetése (2) és split tüdőtranszplantáció (2) volt. Egy fiatal recipiens esetében élő donoros lebenytranszplantáció történt. A betegek átlagéletkora a műtét idején 33,3 év (14 és 58 év között) volt. A 64 transzplantált közül 48-an vannak jelenleg életben.


2021 ◽  
Vol 19 (3) ◽  
pp. 280-283
Author(s):  
Jisu Yu ◽  
Ho Cheol Kim ◽  
Sang-Bum Hong ◽  
Sehoon Choi ◽  
Geun Dong Lee ◽  
...  

2020 ◽  
Vol 41 (S1) ◽  
pp. s357-s357
Author(s):  
Scott Curry ◽  
Danielle Gill ◽  
Aisha Vanderhorst ◽  
Kate Kiley ◽  
Carolina Cassandra Salgado

Background: Allogeneic bone marrow transplant (BMT) as well as liver, heart, and lung transplant patients have high reported incidence rates of Clostridioides difficile infection (CDI). The prevalence and incidence of asymptomatic colonization with Clostridioides difficile (ACCD) in this group is not known. Methods: ACCD was defined as the presence of C. difficile on screening cultures without positive clinical testing for CDI ±1 week from the date of sampling. Patients undergoing BMT as well as liver, heart, and lung transplants at MUSC between October 2017 and October 2019 were cultured for C. difficile at admission for transplant then once weekly during inpatient admissions and at each outpatient follow-up for 90 days after transplantation. Testing for CDI occurred at the discretion of treating physicians and was done by PCR. Transient ACCD was defined as a positive culture from samples collected <7 days apart, and persistent ACCD was defined as having 2 or more positive cultures collected a minimum of 7 days apart. Results: The baseline prevalences of ACCD were 1 of 5 (20%), 0 of 2 (0%), 1 of 40 (3%), and 2 of 16(13%) for lung, heart, liver and BMT patients, respectively. Of 63 patients, 3 had a pretransplant history of CDI, 2 of whom had baseline ACCD. Incident ACCD occurred in 23 of 63 patients (37%) (Table 1). Overall, ACCD was observed in 30 of 63 patients (48%). Of the 30 patients with ACCD, 14 displayed persistent asymptomatic colonization, whereas 16 displayed transient asymptomatic colonization. Also, 5 patients in the cohort were diagnosed with CDI after transplantation, of whom 3 had ACCD prior to or following CDI. Conclusions: The baseline prevalence of C. difficile colonization in transplant patients (6.3%) was not substantially greater than those observed in recent studies of hospitalized inpatients, but the incidence of new colonization events (37%) was high in this patient population with numerous pretransplant risk factors for CDI.Funding: NoneDisclosures: None


Sign in / Sign up

Export Citation Format

Share Document